1. Catalogs
  2. Bard Access Systems
  3. GuardIVa® Antimicrobial Hemostatic IV Dressing

GuardIVa® Antimicrobial Hemostatic IV Dressing

GuardIVa® Antimicrobial Hemostatic IV Dressing

GuardIVa® Antimicrobial Hemostatic IV Dressing

Product catalog summary
Introduction
The document discusses the GuardIVa® Antimicrobial Hemostatic IV Dressing, highlighting its dual functionality in reducing bacteria and controlling bleeding at catheter insertion sites.
Specifications
The GuardIVa® dressing contains Chlorhexidine Gluconate (CHG) to reduce bacteria by 99.99% and M·DOC™ (microdispersed oxidized cellulose) to control bleeding. It provides antimicrobial protection for up to 7 days and is effective against 8 microorganisms commonly associated with catheter-related bloodstream infections (CRBSI).
Procedures and Testing
In vitro and in vivo tests demonstrate the dressing's efficacy in reducing bacterial growth and controlling bleeding. It significantly lowers skin microflora re-growth at day 7 and day 10 post-application.
Indications for Use
The dressing is intended for use as a hydrophilic wound dressing to absorb exudate and protect catheter sites, including IV catheters and percutaneous devices. It is also indicated for controlling surface bleeding from percutaneous catheters and vascular access sites.
Precautions and Warnings
The dressing is not intended to treat infections and should not be used on patients with known sensitivity to chlorhexidine gluconate. Potential reactions include irritation and allergic responses, necessitating immediate discontinuation and medical consultation if severe.
Conclusion
The GuardIVa® dressing offers a balanced approach to wound care by providing both antimicrobial protection and hemostatic benefits, making it a valuable tool in managing catheter-related procedures.
See more

Catalog excerpts

GuardIVa® Antimicrobial Hemostatic IV Dressing-1

Antimicrobial Hemostatic IV Dressing GUARD DOWN ACCESS SYSTEMS

 Open the catalog to page 1
GuardIVa® Antimicrobial Hemostatic IV Dressing-3

Why settle for a dressing that simply reduces bacteria? The GuardIVa® dressing reduces 99.99% of bacteria† AND controls bleeding‡. As demonstrated through in vitro testing. Data on file. As demonstrated through in vivo testing. Data on file. Simulated testing may not be indicative of actual clincial outcomes.

 Open the catalog to page 3
GuardIVa® Antimicrobial Hemostatic IV Dressing-4

The GuardIVa® dressing not only reduces bacteria†, but also controls surface bleeding‡. The GuardIVa® dressing contains Chlorhexidine Gluconate (CHG) sufficient to reduce bacteria by 4 logs (or 99.99%)†, while also allowing healing more consistent with that of untreated wounds‡. What’s more, the GuardIVa® dressing provides hemostasis and antimicrobial protection† in the most critical 24 hours after catheter placement and provides up to 7 days of sustained antimicrobial protection within the dressing. The GuardIVa® dressing is the ONLY antimicrobial dressing indicated to control surface bleeding...

 Open the catalog to page 4
GuardIVa® Antimicrobial Hemostatic IV Dressing-5

BACTERIAL GROWTH The GuardIVa® dressing was tested against 8 microorganisms commonly associated with catheterrelated bloodstream infections (CRBSI). It has been shown to reduce these bacteria by 4 logs or 99.99%†, and suppress re-growth of microorganisms on the skin‡. In an in vivo test demonstrating the GuardIVa® dressing’s ability to suppress re-growth of skin microflora following skin preparation on healthy human volunteers, the GuardIVa® dressing significantly lowered re-growth of skin microflora at day 7 and day 10 compared to the control‡. The GuardIVa® dressing contains a controlled amount...

 Open the catalog to page 5
GuardIVa® Antimicrobial Hemostatic IV Dressing-6

GuardIVa® dressing Indications for Use: The GuardIVa Antimicrobial Hemostatic IV Dressing is intended for use as a hydrophilic wound dressing to absorb exudate, cover and protect catheter sites. Common applications include IV catheters, other intravenous catheters and percutaneous devices. It is also indicated for control of surface bleeding from percutaneous catheters and vascular access sites. ® Additional Information: The GuardIVa® dressing is not clinically tested for its activity to reduce local infections, catheter related blood stream (CRBSI), and skin colonization of microorganisms commonly...

 Open the catalog to page 6
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.